1. [The role of dopamine receptors in the modulation of mononuclear phagocytes in multiple sclerosis].
- Author
-
Lopatina AV, Sviridova AA, Belousova OO, Kuzmina US, and Melnikov MV
- Subjects
- Humans, Adult, Female, Male, Monocytes metabolism, Monocytes immunology, Receptors, Dopamine D2 metabolism, Lipopolysaccharides pharmacology, Cells, Cultured, Lipopolysaccharide Receptors metabolism, Middle Aged, Interferon-gamma metabolism, Interleukin-6 metabolism, Interleukin-1beta metabolism, Multiple Sclerosis, Relapsing-Remitting metabolism, Multiple Sclerosis, Relapsing-Remitting immunology, Receptors, Dopamine D1 metabolism, Macrophages metabolism, Macrophages immunology
- Abstract
Objective: To investigate the role of dopamine receptor D
1 DR and D2 DR in the production of cytokines interleukin-6 (IL-6) and IL-1β by monocytes and macrophages in patients with relapsing-remitting multiple sclerosis (MS)., Material and Methods: Ten patients with relapsing-remitting MS and 10 healthy subjects were examined. The level of IL-6 and IL-1β production was assessed in culture supernatants obtained from CD14+ monocytes or macrophages stimulated with interferon-γ (IFN-γ) and lipopolysaccharide (LPS). To study the role of dopamine receptors in the regulation of CD14+ monocytes or macrophages, samples of cells were incubated in the presence of specific D1 DR or D2 DR antagonists, after which IFN-γ/LPS were added to the cultures. Levels of cytokines in culture supernatants were measured by enzyme-linked immunosorbent assay., Results: The production of IL-6 and IL-1β by CD14+ monocytes and macrophages was comparable between the groups. Blockade of D1 DR suppressed cytokine production by CD14+ monocytes and macrophages in both groups. In contrast, blockade of D2 DR increased the production of cytokines by CD14+ monocytes and did not affect cytokine production by macrophages in both groups., Conclusions: Targeting of dopaminergic receptors could be considered as an additional mechanism of immunomodulation in MS with both pro- and anti-inflammatory effects on cells of the innate immune system.- Published
- 2024
- Full Text
- View/download PDF